Form 4: Haemonetics SVP Laurie Miller Reports Stock Transactions

Haemonetics Corporation SVP of Human Resources Laurie A. Miller reported the vesting of restricted stock units and associated tax withholding.

Summary

• Laurie A. Miller, SVP of Human Resources at Haemonetics Corporation, executed two transactions on May 15, 2026.
• 948 shares were withheld at a price of $56.29 per share to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
• 13,323 RSUs were acquired as a new grant under the 2019 Long-Term Incentive Compensation Plan.
• Following these transactions, the reporting person holds a total of 41,300 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation that does not signal a change in company strategy or financial health.

Positives

• The acquisition of 13,323 RSUs indicates continued alignment of executive compensation with long-term shareholder value through equity-based incentives.

Negatives

• The transaction involved a mandatory tax withholding of 948 shares, which is a standard administrative event rather than a market-driven sale.

Risks

• The value of the acquired RSUs is subject to future market fluctuations in Haemonetics Corporation common stock.

Future Outlook

The newly granted 13,323 RSUs will vest in three annual installments: 40% on the first anniversary, 40% on the second, and 20% on the third anniversary of the grant date.

Management Comments

• Each RSU represents a contingent right to receive one share of the Issuer's common stock when vested.

Industry Context

StockSavvy.ai notes that this filing represents standard executive equity compensation activity within the medical technology sector, reflecting typical retention and incentive structures for senior leadership.

Comparison to Industry Standards

• The use of multi-year vesting schedules for RSUs is consistent with standard corporate governance practices for executive compensation in the healthcare equipment industry.
• Tax withholding upon vesting is a standard industry practice for equity-based compensation plans.

Stakeholder Impact

• Minimal impact on shareholders as these transactions are part of established executive compensation plans.

Next Steps

• Vesting of the newly granted 13,323 RSUs according to the three-year schedule.

Key Dates

Keywords

Haemonetics, HAE, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units